Lung Diseases, Obstructive  >>  Veramyst (fluticasone furoate nasal spray)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Veramyst (fluticasone furoate nasal spray) / GSK
NCT01159912: Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents

Completed
3
350
US, Europe
Fluticasone propionate, Fluticasone furoate, Placebo
GlaxoSmithKline
Asthma
01/12
01/12
NCT01436071: Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

Completed
3
248
US, RoW
Fluticasone furoate 50mcg, Placebo
GlaxoSmithKline
Asthma
06/12
08/12
NCT01436110: Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Completed
3
351
US, Europe, RoW
Fluticasone furoate 50mcg, Fluticasone propionate 100mcg, Placebo
GlaxoSmithKline
Asthma
09/12
09/12
NCT01431950: Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents

Completed
3
238
US, Europe, RoW
fluticasone furoate, albuterol/salbutamol
GlaxoSmithKline
Asthma
10/12
10/12

Download Options